Vanderbilt Transplant Center

Emily Sandhaus, RN, and Chris Schwartz, RN, are pre-transplant coordinators for the Vanderbilt Transplant Center.

Pre-transplant coordinators ‘literally on call for something every single day’

Emily Sandhaus’ phone rings in the middle of the night. The voice on the other end tells her a donor heart is available, and it’s in El Paso, Texas. She should pack a bag and report to the Emergency Department at Vanderbilt University Medical Center. A car will take her team to Nashville International Airport, where they will board a charter plane to recover, preserve and transport the heart back to VUMC for transplant.

Vanderbilt Transplant Center achieves new record for total transplants performed in 2020

The Vanderbilt Transplant Center (VTC) established a new record in 2020 for total solid organ transplants, performing 611 life-saving procedures among its adult and pediatric organ transplant programs.

VUMC now leads world in heart transplantation

Vanderbilt University Medical Center performed more heart transplants in 2020 than any other center in the world — 124 adult hearts, 23 pediatric hearts and VUMC’s first heart-lung transplant since 2006.

Challenges, achievements share spotlight in 2020

The year 2020 will forever be defined by the global COVID-19 pandemic, and Vanderbilt University Medical Center’s response to it has been nothing short of stunning.
The entire enterprise — clinical, research and education — began preparing for the pandemic’s impact even before the first cases appeared in Tennessee in March, and that dedicated commitment and unceasing effort did not waver in the long months that followed. But while COVID-19 dominated the news during 2020, there were still many other noteworthy achievements that made headlines during the year.

The Liver Transplant Anesthesia team includes, from left, Clayne Benson, MD, Kevin Furman, MD, Philip Leisy, MD, and Kara Siegrist, MD.

New approach helps conserve blood products for liver transplant patients

Liver transplants have traditionally required a high volume of transfusions of blood products, which comes with several downsides. The products are costly to patients — as high as $15,000 on top of the expense of a transplant. And they are sometimes not well accepted in patients because they degrade over time and are derived from multiple patients.

Collaborative Vanderbilt Lung Institute launches

1 3 4 5 6 7 13